Betahistin-Vertex, tablets 8 mg 30 pcs

Betahistine acts mainly on histamine H1- and H3-receptors of the inner ear and vestibular nuclei of the CNS. By direct agonist effect on H]-receptors of the inner ear vessels, as well as indirectly through the effect on Hz-receptors, it improves microcirculation and capillary permeability, normalizes the endolymph pressure in the labyrinth and cochlea. At the same time, betahistine increases blood flow in the basilar artery.

It has a pronounced central effect, being an inhibitor of Hz-receptor nuclei of the vestibular nerve. It improves conduction in neurons of vestibular nuclei at brainstem level.

The clinical manifestation of the above properties is reduction of the frequency and intensity of dizziness, reduction of tinnitus, improvement of hearing if it is reduced.

Indications

Dizziness, Meniere’s Disease, Impaired cerebral circulation

• treatment and prevention of vestibular vertigo of various origins
• ./li>
• syndromes including vertigo and headache, tinnitus, progressive hearing loss, nausea and vomiting
• Meniere’s disease or syndrome.

.

Active ingredient

Betahistine

Composition

active ingredient:

betahistine dihydrochloride – 8 mg

excipients:

microcrystalline cellulose – 6.64 mg,

lactose monohydrate – 40 mg,

citric acid monohydrate – 2.5 mg,

/p>

colloidal silica – 3.75 mg,

talcum powder – 3.1 mg,

calcium stearate – 1.25 mg;

.

How to take, the dosage

Betahistine is administered orally with meals.

Contraindications

Hypersensitivity to any of the ingredients of the drug children under 18 years of age (due to lack of data).

With caution

Gastrointestinal ulcers (including anamnesis), pheochromocytoma. bronchial asthma. These patients should be regularly monitored during the treatment period.

.

Overdose

Two tablets three times a day.

Emprovement is usually seen at the beginning of therapy; stable therapeutic effect occurs after two weeks of treatment and can build up over several months of treatment. Treatment is prolonged. The length of time we have to take the drug is individualized.

“

Pregnancy use

There is insufficient data to assess the effect of the drug during pregnancy and lactation.

In this regard, administration during pregnancy is not recommended. Breast-feeding should be stopped during the treatment period.

.

Similarities

Betaserk, Vestibo, Betahistine, Betahistine NW, Tagista, Vertran